Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome

9,10-Phenanthrenequinone Induces Monocytic Differentiation of U937 Cells through Regulating Expression of Aldo-Keto Reductase 1C3

(2015) Toshiyuki Matsunaga et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10

(2014) Toshiyuki Matsunaga et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Structure and Regulation of Soluble Guanylate Cyclase

(2012) Emily R. Derbyshire et al.   Annual Review of Biochemistry

Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers

(2012) Toshiyuki Matsunaga et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung c

(2012) Janica C. Wong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Involvement of the aldo–keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms

(2011) Toshiyuki Matsunaga et al.   ANTI-CANCER DRUGS

Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK

(2011) Joydeep Das et al.   BIOCHEMICAL PHARMACOLOGY

Human aldo–keto reductases 1B1 and 1B10: A comparative study on their enzyme activity toward electrophilic carbonyl compounds

(2011) Yi Shen et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Nitric Oxide and Cancer: The Emerging Role of S-Nitrosylation

(2011) E. Aranda et al.   CURRENT MOLECULAR MEDICINE

Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo–keto reductase 1B10

(2011) Midori Soda et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Selective Inhibition of the Tumor Marker Aldo-keto Reductase Family Member 1B10 by Oleanolic Acid

(2011) Mayuko Takemura et al.   JOURNAL OF NATURAL PRODUCTS

Thiol-Based Redox Switches and Gene Regulation

(2010) Haike Antelmann et al.   ANTIOXIDANTS & REDOX SIGNALING

Properties and tissue distribution of a novel aldo–keto reductase encoding in a rat gene (Akr1b10)

(2010) Satoshi Endo et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Roles of rat and human aldo–keto reductases in metabolism of farnesol and geranylgeraniol

(2010) Satoshi Endo et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy

(2010) David Hirst et al.   CURRENT PHARMACEUTICAL DESIGN

Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells

(2010) Yidan Lin et al.   LUNG CANCER

Chemical Biology of Peroxynitrite: Kinetics, Diffusion, and Radicals

(2009) Gerardo Ferrer-Sueta et al.   ACS Chemical Biology

Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids

(2009) Satoshi Endo et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Identification and expression analysis of the aldo–ketoreductase1-B10 gene in primary malignant liver tumours

(2009) Stefan Heringlake et al.   JOURNAL OF HEPATOLOGY

Structure-Guided Design, Synthesis, and Evaluation of Salicylic Acid-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human 20α-Hydroxysteroid Dehydrogenase (AKR1C1)

(2009) Ossama El-Kabbani et al.   JOURNAL OF MEDICINAL CHEMISTRY

Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes

(2008) Hans-Jörg Martin et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Oxidized Low-Density Lipoproteins Trigger Endoplasmic Reticulum Stress in Vascular Cells

(2008) Marie Sanson et al.   CIRCULATION RESEARCH